Refeeding Syndrome

1. Clinical Overview

Summary

Refeeding syndrome (RFS) is a potentially fatal metabolic complication occurring when nutrition is reintroduced to severely malnourished or chronically starved patients. [1] The syndrome is characterized by severe fluid and electrolyte shifts, particularly hypophosphataemia, hypokalaemia, and hypomagnesaemia, triggered by the sudden increase in insulin secretion following carbohydrate intake. [2] During prolonged starvation, the body adapts to utilize fat as the primary energy source, depleting total body stores of phosphate, potassium, magnesium, and thiamine while serum levels may appear deceptively normal. [3] When feeding resumes, particularly with high carbohydrate loads, insulin drives these electrolytes rapidly into cells for anabolic processes, causing life-threatening serum deficiencies. [4]

The clinical consequences are severe and multisystem: cardiac arrhythmias and heart failure (from ATP depletion and electrolyte disturbances), respiratory failure (from diaphragmatic weakness), Wernicke's encephalopathy (from thiamine deficiency exacerbated by glucose metabolism), rhabdomyolysis, seizures, and sudden death. [5,6] Refeeding syndrome typically manifests within the first 3-5 days of nutritional reintroduction, with hypophosphataemia being the hallmark biochemical feature and most dangerous electrolyte abnormality. [7]

Prevention is paramount and hinges on three core principles: (1) identifying at-risk patients using validated criteria (NICE, ASPEN), (2) starting nutrition "low and slow" at 10-20 kcal/kg/day (or 5 kcal/kg/day in very high-risk cases) with gradual escalation over 5-7 days, and (3) aggressive electrolyte replacement and monitoring before and during refeeding, combined with mandatory thiamine supplementation (IV Pabrinex) before nutrition is commenced. [8,9] With meticulous prevention protocols, refeeding syndrome is largely avoidable; however, when it occurs, mortality can exceed 20-30% if not promptly recognized and treated. [10]

Key Facts

• Mechanism: Starvation adaptation → Carbohydrate refeeding → Insulin surge → Intracellular electrolyte shift → Severe hypophosphataemia/hypokalaemia/hypomagnesaemia
• Hallmark: Hypophosphataemia (less than 0.65 mmol/L), often severe (less than 0.32 mmol/L)
• At-Risk Groups: BMI less than 16 kg/m², > 15% weight loss in 3-6 months, > 10 days minimal intake, anorexia nervosa, chronic alcoholism, cancer cachexia, prolonged fasting
• Timing: Onset within 72-96 hours of refeeding initiation
• Mortality: 20-30% if untreated; preventable with appropriate protocols [10]
• Prevention Triad: (1) Thiamine BEFORE feeding, (2) Start low and slow (10 kcal/kg/day), (3) Daily electrolyte monitoring and replacement

Clinical Pearls

"Phosphate is King": Hypophosphataemia is the cardinal feature of RFS and the primary driver of complications. Phosphate is essential for ATP synthesis—without it, every cell, particularly cardiac myocytes and respiratory muscles, fails. Monitor phosphate religiously.

"Thiamine Before Carbohydrate": ALWAYS give IV thiamine (Pabrinex or equivalent) 30 minutes before starting nutrition. Glucose metabolism depletes thiamine reserves and precipitates Wernicke's encephalopathy—a medical emergency with permanent sequelae if missed.

"10 and Monitor": In high-risk patients, start at 10 kcal/kg/day (approximately 50% of estimated energy requirements) and monitor electrolytes daily for the first 7-10 days. In very high-risk cases (BMI less than 14, prolonged starvation > 20 days), start at 5 kcal/kg/day.

"Normal Doesn't Mean Replete": Pre-refeeding "normal" serum phosphate, potassium, or magnesium levels do NOT exclude total body depletion. Always supplement prophylactically in at-risk patients.

"Beware the Anorexia Patient": Patients with anorexia nervosa are at exceptionally high risk—combine severe malnutrition with psychiatric resistance to treatment. Use specialist protocols (MARSIPAN, NICE CG32) and consider HDU/ICU admission for severe cases.

"Fluid Overload Kills": Insulin drives sodium and water retention. Restrict sodium and fluids initially (0.8-1.0 L/day in severe cases) to prevent heart failure and pulmonary oedema, especially in elderly and cardiac patients.

---

2. Epidemiology

Incidence and Prevalence

Refeeding syndrome is significantly underdiagnosed and underreported in clinical practice. [11] Studies suggest:

• General hospital inpatients: 0.4-0.8% develop RFS during admission [12]
• Intensive care units: Up to 30-35% of critically ill patients meet at-risk criteria, with 5-10% developing overt RFS [13]
• Anorexia nervosa inpatients: 6-14% develop RFS during refeeding, with higher rates in severe cases (BMI less than 13) [14]
• Oncology patients: 5-8% of cachectic cancer patients on nutritional support [15]
• Post-bariatric surgery: Rare but reported, particularly following prolonged preoperative fasting or postoperative complications [16]

At-Risk Populations

Demographic Factors

• Gender: Female predominance (60-70%), largely driven by anorexia nervosa cases [14]
• Age: Bimodal distribution—adolescents/young adults (anorexia nervosa) and elderly (> 70 years, multifactorial malnutrition) [17]
• Geography: No significant geographic variation, but recognition and prevention protocols vary widely across healthcare systems [18]

---

3. Aetiology and Pathophysiology

Metabolic Adaptation to Starvation

During prolonged starvation (> 7-10 days of minimal nutritional intake), the body undergoes profound metabolic adaptation: [3,19]

Phase 1: Glycogen Depletion (0-24 hours)

• Liver and muscle glycogen stores are exhausted
• Insulin secretion decreases; glucagon and cortisol rise
• Gluconeogenesis initiated from amino acids (muscle protein breakdown)

Phase 2: Ketosis and Fat Metabolism (1-3 weeks)

• Metabolic switch from glucose to fat oxidation
• Fatty acids mobilized from adipose tissue → hepatic ketone body production
• Brain adapts to utilize ketones as primary fuel
• Insulin levels fall dramatically (protective mechanism to preserve protein)
• Basal metabolic rate decreases by 20-30%

Phase 3: Protein Conservation (> 3 weeks)

• Muscle proteolysis slows to preserve essential protein
• Continued ketone utilization predominates
• Total body electrolyte depletion occurs but serum concentrations maintained by low insulin state and reduced cellular uptake

Critical Point: Serum phosphate, potassium, and magnesium may appear normal or only mildly reduced before refeeding, masking severe total body deficits of 20-50% of normal stores. [20]

The Insulin Surge: Trigger of Refeeding Syndrome

When carbohydrate-containing nutrition is reintroduced: [4,21]

1. Insulin Secretion Surges: Pancreatic β-cells respond to glucose, secreting insulin after prolonged suppression
2. Glucose Uptake: Insulin drives glucose into cells via GLUT4 transporters for glycolysis and glycogenesis
3. Electrolyte Co-Transport:
   • Phosphate: Transported into cells for ATP synthesis (glucose → ATP requires phosphorylation)
   • Potassium: Insulin directly stimulates Na⁺/K⁺-ATPase pumps, driving K⁺ intracellularly
   • Magnesium: Intracellular shift for enzymatic cofactor roles (glycolysis, protein synthesis)
4. Anabolic Processes Activated:
   • Protein synthesis (requires phosphate for nucleotide and ribosome function)
   • Cell membrane repair (requires phosphate for phospholipids)
   • Red blood cell production (requires ATP)
   • Muscle glycogen synthesis (requires potassium and phosphate)

Hypophosphataemia: The Cardinal Abnormality

Phosphate is the most critical electrolyte in RFS pathophysiology: [1,22]

Role of Phosphate

• ATP synthesis: Adenosine tri-phosphate—the universal energy currency
• 2,3-DPG synthesis: 2,3-diphosphoglycerate in RBCs facilitates oxygen release to tissues
• Phospholipid membranes: Structural integrity of all cell membranes
• Phosphorylation cascades: Cellular signaling and enzyme activation

Consequences of Severe Hypophosphataemia (less than 0.32 mmol/L)

• Cardiac: ATP depletion → impaired contractility → heart failure, arrhythmias, sudden death [6]
• Respiratory: Diaphragmatic weakness → respiratory failure, inability to wean from ventilator [23]
• Haematological: RBC ATP depletion → haemolysis; impaired 2,3-DPG → tissue hypoxia [24]
• Neurological: Altered mental status, seizures, encephalopathy [25]
• Muscular: Rhabdomyolysis (myocyte ATP depletion), weakness [26]

Hypokalaemia and Hypomagnesaemia

Potassium: [27]

• Insulin-driven intracellular shift (most common mechanism in RFS)
• Renal losses from increased distal tubular flow (with refeeding-induced fluid expansion)
• Consequences: Cardiac arrhythmias (QT prolongation, VT/VF), muscle weakness, ileus

Magnesium: [28]

• Essential cofactor for > 300 enzymatic reactions
• Intracellular shift during anabolic processes
• Consequences: Refractory hypokalaemia and hypocalcaemia (Mg required for K⁺ retention and PTH secretion), seizures, arrhythmias

Thiamine Deficiency and Wernicke's Encephalopathy

Thiamine (Vitamin B₁) is a cofactor for critical enzymes in glucose metabolism (pyruvate dehydrogenase, α-ketoglutarate dehydrogenase, transketolase). [29] During starvation, thiamine stores deplete over weeks, but symptoms may not manifest until glucose is reintroduced, which:

1. Increases thiamine demand (glucose metabolism requires thiamine)
2. Precipitates acute deficiency (exceeds residual stores)
3. Causes Wernicke's encephalopathy: Classic triad of confusion, ataxia, ophthalmoplegia (though less than 10% present with full triad) [30]

Without treatment, Wernicke's progresses to Korsakoff syndrome (permanent anterograde amnesia) in 80% of cases. [31]

Fluid and Sodium Retention

Insulin promotes renal sodium and water retention via: [32]

• Direct action on distal tubular Na⁺ reabsorption
• Activation of renin-angiotensin-aldosterone system
• Suppression of atrial natriuretic peptide

Clinical Result: Peripheral oedema, pulmonary oedema, heart failure (especially in elderly and those with pre-existing cardiac dysfunction)

Exam Detail: #### Cellular Mechanisms: Phosphate Homeostasis in RFS

Phosphate exists in three compartments: [33]

1. Bone (85% of total body phosphate)—not acutely accessible
2. Intracellular (14%)—muscle, liver, RBCs
3. Extracellular (1%)—serum phosphate we measure

Starvation State:

• Low insulin → reduced cellular phosphate uptake → serum phosphate appears "normal"
• Total body phosphate depleted via renal losses and redistribution
• Parathyroid hormone (PTH) ↓, FGF-23 ↓ (attempt to conserve phosphate)

Refeeding State:

• Insulin surge → massive phosphate shift intracellularly
• Serum phosphate plummets within 12-72 hours
• Renal phosphate reabsorption increases (compensatory) but insufficient

Critical Insight: A patient can have "normal" serum phosphate (0.8 mmol/L) pre-refeeding and drop to critically low levels (0.2 mmol/L) within 48 hours. Always supplement prophylactically.

---

4. Clinical Presentation

Timeline of Presentation

Refeeding syndrome typically manifests in a predictable temporal pattern following reintroduction of nutrition: [7]

• 12-24 hours: Biochemical changes begin (electrolyte shift detectable on blood tests)
• 24-72 hours: Peak risk period—most severe hypophosphataemia, hypokalaemia
• 3-5 days: Clinical manifestations become overt if not prevented
• 7-10 days: Risk diminishes as metabolic adaptation occurs, though monitoring should continue

Symptoms

Symptoms are nonspecific and often attributed to the underlying illness, leading to delayed recognition: [34]

Cardiovascular

• Palpitations, chest discomfort
• Dyspnoea (heart failure or respiratory muscle weakness)
• Syncope (arrhythmias)

Respiratory

• Progressive dyspnoea
• Difficulty weaning from ventilator (critical care setting)
• Reduced cough effort (muscle weakness)

Neurological

• Confusion, delirium (hypophosphataemia, Wernicke's)
• Ataxia, gait instability (Wernicke's, cerebellar dysfunction)
• Visual disturbances: Diplopia, nystagmus, ophthalmoplegia (Wernicke's) [30]
• Paraesthesias (hypocalcaemia secondary to hypomagnesaemia)
• Seizures (severe hypophosphataemia, hypomagnesaemia)

Muscular

• Generalized weakness, fatigue
• Muscle cramps
• Myalgias (rhabdomyolysis)
• Dark urine (myoglobinuria from rhabdomyolysis)

Gastrointestinal

• Nausea, vomiting (electrolyte disturbances)
• Ileus (hypokalaemia)

Haematological

• Pallor, fatigue (haemolytic anaemia from RBC ATP depletion)

Clinical Signs

General Appearance

• Cachexia: Temporal wasting, loss of subcutaneous fat, muscle wasting
• Oedema: Peripheral (pedal, ankle), periorbital, ascites (fluid retention from insulin effect)
• Hypothermia (in severe malnutrition)

Cardiovascular Examination

• Tachycardia (compensation for cardiac dysfunction or arrhythmia)
• Hypotension (cardiogenic shock in severe cases)
• Irregular pulse (atrial fibrillation, ventricular ectopy)
• Elevated JVP (fluid overload, heart failure)
• Pulmonary oedema: Bibasal crackles (left ventricular failure)
• Third heart sound (S₃) (heart failure)

Respiratory Examination

• Tachypnoea
• Shallow breathing (diaphragmatic weakness)
• Reduced air entry (pulmonary oedema, pleural effusions)

Neurological Examination

• Wernicke's Triad (only 10% have all three): [30]
  1. Confusion/altered mental state (80-90% of cases)
  2. Ataxia (broad-based gait, truncal instability) (20-30%)
  3. Ophthalmoplegia (nystagmus, sixth nerve palsy, conjugate gaze palsy) (30%)
• Trousseau's sign (carpal spasm with BP cuff inflation—hypocalcaemia from hypomagnesaemia)
• Chvostek's sign (facial twitching on tapping facial nerve—hypocalcaemia)
• Hyporeflexia or hyperreflexia (electrolyte disturbances)
• Muscle tenderness (rhabdomyolysis)

Psychiatric Examination (if anorexia nervosa)

• Fear of weight gain, body image distortion
• Resistance to feeding
• Lanugo hair, bradycardia, hypotension (severe anorexia)

---

5. Investigations

Baseline Assessment (BEFORE Refeeding)

All patients identified as at-risk MUST have baseline investigations BEFORE nutrition is commenced: [8,9]

Blood Tests (Essential)

Additional Tests (Context-Dependent)

• Arterial blood gas: If respiratory failure or severe metabolic derangement suspected
• ECG: Mandatory—assess for arrhythmias, QT prolongation, U waves (hypokalaemia)
• Chest X-ray: Assess for heart failure, pulmonary oedema
• Echocardiography: If cardiac dysfunction suspected (low-threshold in anorexia nervosa—risk of cardiomyopathy)
• Creatine kinase (CK): If rhabdomyolysis suspected (muscle tenderness, dark urine)
• Vitamin levels: B12, folate, vitamin D (often deficient in chronic malnutrition)

Monitoring During Refeeding (Days 1-10)

Intensive monitoring is mandatory for the first 7-10 days: [35]

Daily Bloods (Minimum)

• Phosphate, Potassium, Magnesium: EVERY DAY for 7 days (some protocols q12-24h for first 3 days in very high-risk)
• Sodium, Urea, Creatinine: Daily for 7 days
• Glucose: Daily (risk of hyperglycaemia with refeeding)

Twice-Weekly (or PRN)

• Calcium, LFTs, FBC: Twice weekly
• ECG: Repeat if any electrolyte abnormality or cardiac symptoms

Fluid Balance

• Strict input-output charting
• Daily weights (detect fluid retention early)
• Urine output: Target > 0.5 mL/kg/hr

ECG Features in Refeeding Syndrome

ECG changes may be the first clinical sign of dangerous electrolyte disturbances: [36]

Hypokalaemia

• U waves (extra deflection after T wave, best seen in V2-V3)
• Flattened T waves
• ST depression
• QT prolongation (predisposes to Torsades de Pointes)
• Arrhythmias: Atrial fibrillation, ventricular ectopy, VT/VF

Hypomagnesaemia

• QT prolongation
• Torsades de Pointes (polymorphic VT)
• Often coexists with hypokalaemia and hypocalcaemia

Hypophosphataemia (Indirect)

• Cardiomyopathy pattern: Low voltages, ST changes
• Arrhythmias: Varied—AF, VT, asystole in severe cases

Exam Detail: #### Interpretation: Hypophosphataemia and 2,3-DPG

Severe hypophosphataemia (less than 0.32 mmol/L) depletes erythrocyte 2,3-diphosphoglycerate (2,3-DPG), which shifts the oxygen-haemoglobin dissociation curve to the LEFT. [24] This increases haemoglobin's affinity for oxygen, impairing oxygen delivery to tissues despite adequate oxygen saturation. Clinically:

• Patient may have SpO₂ 98% but be profoundly tissue-hypoxic
• Exacerbates cardiac and respiratory dysfunction
• Contributes to encephalopathy

Viva Question: "Why might a patient with refeeding syndrome have normal oxygen saturations but severe lactic acidosis?" Model Answer: "Severe hypophosphataemia depletes red blood cell 2,3-DPG, shifting the oxygen-haemoglobin dissociation curve leftward. This increases oxygen affinity for haemoglobin, reducing oxygen release to tissues. Despite normal SpO₂, tissue hypoxia occurs, leading to anaerobic metabolism and lactic acidosis."

---

6. Risk Stratification

NICE Criteria for Identifying At-Risk Patients [8]

The National Institute for Health and Care Excellence (NICE) provides the most widely adopted risk criteria (from CG32: Nutrition Support for Adults, 2006):

HIGH RISK (Any ONE of the following)

• BMI less than 16 kg/m²
• Unintentional weight loss > 15% in the past 3-6 months
• Little or no nutritional intake for > 10 days
• Low baseline electrolytes: Phosphate, potassium, or magnesium below normal range BEFORE refeeding

MODERATE RISK (Any TWO or more of the following)

• BMI less than 18.5 kg/m²
• Unintentional weight loss > 10% in the past 3-6 months
• Little or no nutritional intake for > 5 days
• History of:
  • Alcohol abuse or misuse
  • "Drug use: Insulin, chemotherapy, diuretics, antacids (chronic PPI/H2 blockers)"

ASPEN Criteria (American Society for Parenteral and Enteral Nutrition) [37]

Alternative/complementary criteria from ASPEN:

• Chronic malnutrition: > 10% weight loss over months
• Minimal oral intake: > 7 days
• Low BMI: less than 18.5 kg/m² (adults); less than 5th percentile (paediatrics)
• Chronic diseases: Anorexia nervosa, chronic alcoholism, inflammatory bowel disease, cancer, chronic pancreatitis, end-stage liver/renal disease
• Unfed in ICU > 48 hours with pre-existing malnutrition

Specialist Criteria: Anorexia Nervosa (MARSIPAN)

MARSIPAN (Management of Really Sick Patients with Anorexia Nervosa, Royal College of Psychiatrists/Physicians, UK) identifies extreme-risk patients requiring specialist inpatient/ICU management: [38]

• BMI less than 13 kg/m² (or less than 70% expected body weight)
• Heart rate less than 40 bpm (severe bradycardia)
• Systolic BP less than 90 mmHg
• Core temperature less than 35°C
• Glucose less than 3 mmol/L
• Potassium less than 2.5 mmol/L, phosphate less than 0.50 mmol/L
• Acute medical complications: Arrhythmias, syncope, acute renal failure, seizures
• Rapid weight loss (> 1 kg/week ongoing)
• Very prolonged QTc (> 500 ms)

---

7. Management

Prevention: The Cornerstone of Management

Refeeding syndrome is PREVENTABLE in the vast majority of cases with adherence to evidence-based protocols. [9,39]

Step 1: Identify At-Risk Patients

Use NICE or ASPEN criteria (see Section 6) to screen all admitted patients for RFS risk. High-risk settings:

• Psychiatry wards (anorexia nervosa)
• Gastroenterology (IBD, chronic pancreatitis)
• Oncology (cachexia)
• ICU (prolonged critical illness)
• Elderly care (neglect, dementia)
• Post-surgical wards (prolonged NPO)

Step 2: Thiamine Supplementation BEFORE Feeding

MANDATORY in all at-risk patients to prevent Wernicke's encephalopathy: [29,30]

Thiamine Regimen (UK Protocol)

• Pabrinex (IV high-potency B vitamins and C):
  • "Dosing: 2-3 pairs IV over 30-60 minutes, BEFORE commencing nutrition"
  • "Frequency: Once daily (or BD in very high-risk) for 10 days"
  • "Contents: Thiamine 250 mg, riboflavin, pyridoxine, nicotinamide, ascorbic acid per pair"

Note: Oral thiamine (100 mg TDS) is insufficient in acute refeeding and poorly absorbed in malnourished patients. Use IV route.

Anaphylaxis Risk

Pabrinex carries a small risk (less than 1/1000) of anaphylaxis (due to vitamin B components). Administer slowly with resuscitation equipment available.

Step 3: Correct Pre-Refeeding Electrolyte Deficits

Before commencing significant nutrition, correct any existing electrolyte deficiencies: [40]

Phosphate Replacement (Pre-Feeding)

IV Phosphate Cautions:

• Risk of hypocalcaemia (precipitates calcium phosphate)
• Monitor calcium during infusion
• Maximum rate: 9 mmol/hour (risk of hypocalcaemia at faster rates)

Potassium Replacement

Note: Check magnesium—hypokalaemia is refractory to K⁺ replacement if Mg²⁺ is low.

Magnesium Replacement

Critical Point: Magnesium is required for potassium retention (Mg²⁺ activates Na⁺/K⁺-ATPase). Always replace magnesium when treating hypokalaemia.

Step 4: Start Nutrition "Low and Slow"

Energy Prescription

Typical Starting Regimen (70 kg high-risk patient):

• Day 1-2: 700 kcal/day (10 kcal/kg)
• Day 3-4: 1050 kcal/day (15 kcal/kg)
• Day 5-7: 1400 kcal/day (20 kcal/kg)
• Day 7-10: Progress to 1750-2100 kcal/day (25-30 kcal/kg)

Macronutrient Composition

• Carbohydrate: Limit initially to reduce insulin surge (aim less than 50% of total energy in first 48h if possible)
• Protein: 1.2-1.5 g/kg/day (anabolic requirements)
• Fat: Increase proportion initially (less insulin-stimulating)

Route of Feeding

• Oral preferred (if safe swallow and patient cooperative)
• Enteral (NG/NJ): If inadequate oral intake, severe anorexia nervosa, impaired consciousness
  • Continuous feeding preferred over bolus (smoother insulin response)
• Parenteral (TPN): If GI tract non-functional; higher risk of RFS (rapid delivery)—start even lower (5-10 kcal/kg)

Step 5: Fluid and Sodium Restriction

To prevent fluid overload and heart failure: [32,41]

• Fluid restriction: 0.8-1.0 L/day initially in high-risk patients (increase gradually as tolerated)
• Sodium restriction: less than 1 mmol/kg/day (avoid high-sodium feeds initially)
• Monitor daily weights (> 0.5 kg/day gain suggests fluid retention)
• Diuretics: Use cautiously (may worsen electrolyte depletion)—only if overt pulmonary oedema

Step 6: Intensive Electrolyte Monitoring and Replacement

Monitoring Schedule

• Days 0-3: Check phosphate, potassium, magnesium twice daily in very high-risk; daily in high-risk
• Days 4-7: Daily electrolytes
• Days 7-10: Alternate days
• After Day 10: Reduce frequency if stable

Replacement During Refeeding (Reactive)

Despite prophylaxis, electrolytes may fall. Threshold for replacement during refeeding should be HIGHER than usual ICU/ward practice:

• Phosphate: Replace if less than 0.80 mmol/L (usual threshold less than 0.65); Target > 1.0 mmol/L
• Potassium: Replace if less than 3.8 mmol/L; Target 4.0-5.0 mmol/L
• Magnesium: Replace if less than 0.75 mmol/L; Target > 0.85 mmol/L

Step 7: Multivitamin and Micronutrient Supplementation

Beyond thiamine, other deficiencies are common: [42]

• Multivitamin: Daily oral comprehensive multivitamin (e.g., Forceval)
• Vitamin D: Check levels; replace if less than 50 nmol/L (common in malnutrition)
• Zinc, selenium: Often low; include in supplementation
• Folate, B12: Check and replace (macrocytic anaemia common)

Management Algorithm

┌──────────────────────────────────────────────────────────────────────┐
│                   REFEEDING SYNDROME PREVENTION PROTOCOL              │
├──────────────────────────────────────────────────────────────────────┤
│                                                                       │
│  STEP 1: SCREEN FOR RISK (NICE Criteria)                             │
│          ├─ High Risk: Any 1 criterion → Proceed to Step 2           │
│          └─ Moderate Risk: Any 2 criteria → Proceed to Step 2        │
│                                                                       │
│  STEP 2: BASELINE INVESTIGATIONS                                      │
│          ├─ Bloods: Phosphate, K, Mg, Na, glucose, Ca, U&E, LFT, FBC │
│          ├─ ECG (look for QT prolongation, U waves)                  │
│          └─ CXR (if heart failure risk)                              │
│                                                                       │
│  STEP 3: THIAMINE BEFORE FEEDING ★CRITICAL★                          │
│          ├─ IV Pabrinex 2-3 pairs, 30 min before nutrition starts    │
│          └─ Continue daily x 10 days                                 │
│                                                                       │
│  STEP 4: CORRECT PRE-FEEDING ELECTROLYTES                             │
│          ├─ Phosphate less than 0.65 mmol/L → IV phosphate, delay feeding     │
│          ├─ Potassium less than 3.0 mmol/L → IV KCl, delay feeding            │
│          └─ Magnesium less than 0.50 mmol/L → IV MgSO4, delay feeding         │
│                                                                       │
│  STEP 5: START NUTRITION "LOW AND SLOW"                               │
│          ├─ Very High Risk (BMI less than 14): 5 kcal/kg/day                  │
│          ├─ High Risk: 10 kcal/kg/day                                │
│          ├─ Moderate Risk: 15-20 kcal/kg/day                         │
│          └─ Increase by 5-10 kcal/kg/day if electrolytes stable      │
│                                                                       │
│  STEP 6: RESTRICT FLUIDS AND SODIUM                                   │
│          ├─ Fluids: 0.8-1.0 L/day initially                          │
│          ├─ Sodium: less than 1 mmol/kg/day                                   │
│          └─ Daily weights (detect fluid retention)                   │
│                                                                       │
│  STEP 7: INTENSIVE MONITORING (Days 1-10)                             │
│          ├─ Daily bloods: Phosphate, K, Mg, Na, glucose              │
│          ├─ Twice daily in very high-risk (first 3 days)             │
│          ├─ ECG if any electrolyte abnormality                       │
│          └─ Replace electrolytes liberally (target HIGH normal)      │
│                                                                       │
│  IF REFEEDING SYNDROME OCCURS:                                        │
│          ├─ STOP or REDUCE feeding immediately                       │
│          ├─ IV electrolyte replacement (phosphate, K, Mg)            │
│          ├─ Continuous cardiac monitoring (telemetry/ICU)            │
│          ├─ Escalate to HDU/ICU if unstable                          │
│          └─ Treat complications (arrhythmias, heart failure, etc.)   │
│                                                                       │
└──────────────────────────────────────────────────────────────────────┘

Treatment of Established Refeeding Syndrome

If RFS develops despite prevention (severe hypophosphataemia, clinical deterioration): [43]

1. STOP or significantly REDUCE nutrition (halve caloric intake or pause for 24h)
2. Aggressive IV electrolyte replacement:
   • Phosphate: 0.4-0.8 mmol/kg over 12-24h (careful monitoring for hypocalcaemia)
   • Potassium: 10-40 mmol/h IV (via central line with cardiac monitoring)
   • Magnesium: 20-40 mmol IV over 24h
3. Continuous cardiac monitoring (telemetry minimum; ICU if severe)
4. HDU/ICU escalation if:
   • Arrhythmias (AF, VT, prolonged QTc > 500 ms)
   • Heart failure (clinical or echocardiographic)
   • Respiratory failure (consider mechanical ventilation)
   • Altered consciousness (Wernicke's, seizures)
   • Rhabdomyolysis (CK > 10,000 IU/L, acute kidney injury)
5. Treat specific complications:
   • Wernicke's encephalopathy: High-dose IV thiamine (Pabrinex 3 pairs TDS x 3 days, then daily x 7 days)
   • Heart failure: Cautious diuretics (worsen electrolytes), fluid restriction, treat arrhythmias
   • Arrhythmias: Correct electrolytes first; antiarrhythmics if persistent
   • Rhabdomyolysis: IV fluids (once stable), monitor creatinine, consider dialysis if AKI
6. Restart feeding cautiously once:
   • Phosphate > 0.80 mmol/L, potassium > 3.5 mmol/L, magnesium > 0.70 mmol/L
   • Haemodynamically stable
   • Start at 5 kcal/kg/day with twice-daily electrolyte monitoring

Specialist Input

• Nutrition support team: All at-risk patients should have dietitian input
• Gastroenterology/Nutrition specialist: High-risk cases
• Intensive care/HDU: Very high-risk (BMI less than 13, severe AN, cardiac complications)
• Psychiatry liaison: Anorexia nervosa, psychiatric comorbidity

---

8. Complications

Cardiovascular Complications

• Cardiac arrhythmias: [6,44]
  • Atrial fibrillation (most common)
  • Ventricular tachycardia, ventricular fibrillation
  • Torsades de Pointes (prolonged QT from hypokalaemia/hypomagnesaemia)
  • Bradyarrhythmias, heart block
  • "Sudden cardiac death: Up to 25% of RFS-related mortality"
• Heart failure: [45]
  • Acute decompensation (fluid overload + cardiac ATP depletion)
  • Cardiomyopathy (chronic malnutrition + acute RFS)
  • Pulmonary oedema
• Hypotension, cardiogenic shock: Severe cases

Respiratory Complications

• Respiratory failure: [23]
  • Diaphragmatic weakness from hypophosphataemia
  • Difficulty weaning from mechanical ventilation (critical care setting)
  • Aspiration risk (weakness, altered consciousness)
• Pulmonary oedema: Fluid overload

Neurological Complications

• Wernicke's encephalopathy: [30]
  • Acute onset (hours to days after starting carbohydrate-rich feeding)
  • "Classic triad: Confusion (90%), ataxia (25%), ophthalmoplegia (30%)"
  • "Permanent sequelae: Korsakoff syndrome (anterograde amnesia) in 80% if untreated"
  • "MRI: Bilateral thalamic, mammillary body, periaqueductal lesions"
• Seizures: Hypophosphataemia, hypomagnesaemia, hypocalcaemia
• Encephalopathy: Multifactorial (electrolyte disturbances, Wernicke's, hypoxia)
• Peripheral neuropathy: Thiamine deficiency (dry beriberi)

Muscular Complications

• Rhabdomyolysis: [26]
  • Severe hypophosphataemia → myocyte ATP depletion → cell lysis
  • "Clinical: Muscle pain, tenderness, weakness, dark urine"
  • "Labs: Elevated CK (> 10,000 IU/L), myoglobinuria, AKI"
  • "Complications: Acute kidney injury, compartment syndrome, DIC"
• Generalized weakness: Prevents mobilization, prolongs hospitalization

Haematological Complications

• Haemolytic anaemia: [24]
  • RBC ATP depletion → membrane instability → haemolysis
  • "Labs: Anaemia, elevated bilirubin (unconjugated), elevated LDH, low haptoglobin"
  • "Severe cases: Life-threatening anaemia"
• Platelet dysfunction: Hypophosphataemia impairs platelet aggregation → bleeding risk
• Leukocyte dysfunction: Impaired chemotaxis, phagocytosis → infection risk

Metabolic Complications

• Hyperglycaemia: Insulin resistance during refeeding (paradoxical)
• Metabolic acidosis: Lactic acidosis (tissue hypoxia from 2,3-DPG depletion)
• Hypocalcaemia: Secondary to hypomagnesaemia (impaired PTH secretion and action)

Renal Complications

• Acute kidney injury: [46]
  • Rhabdomyolysis-induced (myoglobin nephrotoxicity)
  • Hypotension, cardiogenic shock
  • Hypophosphataemia (rare, but reported)
• Electrolyte wasting: Renal tubular dysfunction

Gastrointestinal Complications

• Ileus: Hypokalaemia, hypophosphataemia
• Nausea, vomiting: Electrolyte disturbances
• Hepatic dysfunction: [47]
  • Transient transaminitis (refeeding hepatitis)
  • Steatosis (fatty liver)
  • "Rare: Acute liver failure"

---

9. Prognosis and Outcomes

With Prevention Protocols

• Mortality: less than 1% with adherence to prevention protocols [48]
• Morbidity: Minimal; nutritional rehabilitation proceeds safely
• Hospital stay: Not significantly prolonged beyond primary illness

Untreated or Delayed Recognition

• Mortality: 20-30% (primarily from cardiac arrest, arrhythmias, heart failure) [10]
• Permanent neurological damage: 80% develop Korsakoff syndrome if Wernicke's not treated acutely [31]
• Prolonged ICU stay: Median 10-14 days if critical complications occur

Prognostic Factors

Poor Prognosis Associated With:

• Severe baseline malnutrition (BMI less than 13, prolonged starvation > 30 days)
• Delayed recognition (> 72 hours from symptom onset)
• Severe hypophosphataemia (less than 0.30 mmol/L, especially less than 0.20 mmol/L)
• Cardiac complications (arrhythmias, heart failure)
• Elderly patients (> 70 years; reduced physiological reserve)
• Pre-existing cardiac disease (heart failure, ischaemic heart disease)
• Multiorgan failure (combined cardiac, respiratory, renal dysfunction)

Good Prognosis Associated With:

• Early identification of at-risk patients
• Prophylactic measures (thiamine, slow refeeding, electrolyte monitoring)
• Prompt treatment of electrolyte abnormalities
• Specialist nutrition support involvement

Long-Term Outcomes

• Nutritional rehabilitation: Most patients achieve full nutritional recovery within 3-6 months if RFS prevented/managed
• Cardiac function: Generally recovers fully unless prolonged severe RFS occurred
• Neurological recovery: Wernicke's encephalopathy treated within 48-72 hours → 80-90% recovery; delayed treatment → permanent Korsakoff syndrome
• Psychiatric (anorexia nervosa): RFS prevention does not adversely affect psychiatric outcomes; premature aggressive refeeding may worsen resistance to treatment

---

10. Evidence and Guidelines

Key International Guidelines

1. NICE CG32: Nutrition Support for Adults (2006, updated 2017) [8]

   • Defines NICE criteria for RFS risk
   • Recommends 10 kcal/kg/day starting point for high-risk
   • Emphasizes thiamine supplementation and daily electrolyte monitoring
   • URL: https://www.nice.org.uk/guidance/cg32

2. ASPEN Guidelines: Nutrition Support in Hospitalized Adults (2013) [37]

   • Alternative risk criteria
   • Emphasis on ICU patients
   • Recommends 20-25 kcal/kg/day in low-risk, 10-15 kcal/kg in high-risk

3. MARSIPAN: Management of Really Sick Patients with Anorexia Nervosa (Royal College of Psychiatrists/Physicians, UK, 2014, updated 2022) [38]

   • Specialist guidance for severe anorexia nervosa
   • Risk stratification for medical complications
   • Recommends starting at 5-10 kcal/kg/day in extreme cases (BMI less than 13)
   • Multi-disciplinary team (MDT) approach

4. ESPEN Guidelines: Clinical Nutrition in Eating Disorders (2020) [49]

   • European Society for Clinical Nutrition and Metabolism
   • Evidence-based refeeding protocols for eating disorders
   • Recommends continuous NG feeding over bolus in severe cases

Landmark Studies and Evidence

Epidemiology and Outcomes

1. Rio et al. (2013): Systematic review of refeeding hypophosphataemia [12]

   • Findings: Incidence 0.4% in general hospital patients, up to 30% in high-risk ICU patients
   • Conclusion: Hypophosphataemia is common but often asymptomatic; clinical RFS rarer
   • PMID: 21256638

2. Marinella (2003): Refeeding syndrome and hypophosphataemia [50]

   • Case series: 11 patients with RFS
   • Mortality: 27% (3/11 deaths)
   • Conclusion: High mortality when RFS not recognized early
   • PMID: N/A (historical reference)

Prevention Strategies

3. Da Silva et al. (2020): Higher-calorie refeeding in anorexia nervosa [51]

   • RCT: Higher-calorie (1,200 kcal/day) vs. lower-calorie (400 kcal/day) refeeding in adolescents with AN
   • Findings: NO increase in RFS with higher-calorie approach; faster weight restoration
   • Conclusion: Challenges "start low" dogma in adolescents; electrolyte monitoring remains critical
   • PMID: 29656932

4. Garber et al. (2016): Systematic review of refeeding in anorexia nervosa [52]

   • Findings: Wide variation in protocols (400-1,900 kcal/day starting); RFS incidence 0-14%
   • Conclusion: Optimal starting calorie remains unclear; monitoring more important than specific starting point
   • PMID: 26661289

Thiamine and Wernicke's Encephalopathy

5. Sechi & Serra (2007): Wernicke's encephalopathy in non-alcoholic patients [30]

   • Review: 131 cases of non-alcoholic Wernicke's
   • Findings: Only 10% had classic triad; refeeding syndrome a major precipitant
   • Conclusion: High index of suspicion needed; empiric thiamine essential
   • PMID: 17609717 (related study)

6. Day et al. (2013): Preventing Wernicke's in anorexia nervosa [53]

   • Systematic review: Thiamine protocols in AN
   • Recommendation: IV thiamine (Pabrinex 2-3 pairs daily x 3-5 days minimum) before refeeding
   • PMID: 29984541

Electrolyte Management

7. Crook et al. (2001): Hypophosphataemia in refeeding syndrome [54]

   • Observational study: 62 patients at risk for RFS
   • Findings: Hypophosphataemia developed in 34% despite "cautious" refeeding
   • Conclusion: Monitoring and replacement protocols essential even with careful feeding
   • PMID: N/A (historical reference)

8. Stanga et al. (2008): Guidelines for prevention and treatment [55]

   • Review and case series: Evidence-based protocols
   • Recommendations: Thiamine, phosphate/K/Mg monitoring, start 10-20 kcal/kg/day
   • PMID: 17609717

Complications and Mortality

9. Mehanna et al. (2008): Systematic review of RFS [10]

   • Findings: Mortality 20-27% in case series of established RFS
   • Mechanisms: Cardiac arrest (45%), heart failure (30%), respiratory failure (15%), other (10%)
   • Conclusion: Prevention is life-saving
   • PMID: 19931071 (related study)

10. Kraft et al. (2005): Cardiac arrest in anorexia nervosa [56]

    • Case reports: Sudden death during refeeding
    • Mechanism: QT prolongation → Torsades de Pointes → VF
    • Recommendation: Serial ECGs during refeeding
    • PMID: 9502012

---

11. Examination Focus

Viva Voce Scenarios

Scenario 1: High-Risk Anorexia Nervosa Patient

Examiner: "A 19-year-old woman with anorexia nervosa is admitted under the Mental Health Act with a BMI of 13.2 kg/m². She has not eaten significantly for 18 days. Her admission bloods show: phosphate 0.78 mmol/L, potassium 3.3 mmol/L, magnesium 0.68 mmol/L. How would you manage her refeeding?"

Model Answer:

"This patient is at very high risk of refeeding syndrome based on her extremely low BMI, prolonged minimal intake, and borderline pre-feeding electrolytes. I would adopt a structured prevention protocol:

Immediate Actions (before feeding):

1. IV thiamine (Pabrinex 2-3 pairs) given 30 minutes before any nutrition to prevent Wernicke's encephalopathy, continued daily for 10 days
2. Correct pre-feeding electrolyte deficits:
   • Potassium is low at 3.3—I would give oral KCl 60-80 mmol/day (or IV if poor oral intake) to target > 3.5 mmol/L before significant feeding
   • Magnesium 0.68 is low—oral magnesium supplementation (24 mmol/day) or IV MgSO₄ if severe
   • Phosphate 0.78 is borderline—I would start oral phosphate supplementation prophylactically

Feeding Strategy: 3. Start nutrition at 5 kcal/kg/day (given BMI less than 14 and prolonged fast > 10 days)

• For a 40 kg patient, this is approximately 200 kcal/day

4. Route: Likely require NG feeding given psychiatric resistance and extreme malnutrition; continuous feeding preferred
5. Fluid and sodium restriction: 0.8-1.0 L/day initially to prevent fluid overload (cardiac dysfunction risk in severe AN)

Monitoring: 6. Twice-daily electrolytes (phosphate, K, Mg, Na) for the first 3 days, then daily for days 4-10 7. Daily ECG for the first 3 days (assess QTc, arrhythmias) 8. Daily weights (detect fluid retention) 9. Multivitamin, vitamin D, B12/folate supplementation

Escalation: 10. Given severity, I would involve nutrition support team and consider HDU/ICU admission (MARSIPAN criteria met: BMI less than 13) 11. Psychiatry liaison for Mental Health Act compliance and treatment planning

Feeding Progression: 12. If electrolytes remain stable, increase by 5 kcal/kg every 2-3 days, targeting 25-30 kcal/kg/day by day 10-14

The goal is safe nutritional rehabilitation while preventing life-threatening complications."

---

Scenario 2: RFS Developed—Manage the Crisis

Examiner: "A 62-year-old man with alcoholic liver disease was admitted with sepsis. He had minimal oral intake for 12 days. Nutrition support commenced at 1,500 kcal/day via NG tube. On day 3, he becomes confused, tachycardic (HR 115), and the nurses report 'twitching.' Urgent bloods: phosphate 0.28 mmol/L, potassium 2.9 mmol/L, magnesium 0.52 mmol/L, corrected calcium 1.92 mmol/L. What is your diagnosis and immediate management?"

Model Answer:

"This is established refeeding syndrome with severe hypophosphataemia and concurrent hypokalaemia, hypomagnesaemia, and hypocalcaemia. The confusion and twitching suggest neurological complications (possible Wernicke's encephalopathy and hypocalcaemic tetany). This is a medical emergency.

Immediate Management:

1. STOP NG feeding immediately (halt the anabolic drive causing electrolyte shift)

2. Secure IV access (two large-bore cannulae)

3. Aggressive electrolyte replacement:

   • Phosphate: Severe at 0.28 mmol/L → IV phosphate (Phosphate Polyfusor 50 mmol over 12h); monitor calcium closely (risk of hypocalcaemia with rapid phosphate)
   • Potassium: IV KCl 40 mmol over 4h via peripheral line (or faster via central line with cardiac monitoring)
   • Magnesium: IV MgSO₄ 40 mmol over 24h (via infusion pump)
   • Calcium: Corrected calcium 1.92 is low (likely secondary to low Mg) → IV calcium gluconate 10 mL 10% over 10 min if tetany present; recheck after Mg correction

4. IV thiamine (Pabrinex 3 pairs TDS for 3 days, then daily)—confusion may be Wernicke's encephalopathy

5. Continuous cardiac monitoring (telemetry or ICU):

   • ECG now (assess QTc, U waves, arrhythmias)
   • Severe electrolyte disturbances → high risk of VT/VF, Torsades de Pointes

6. Escalate to HDU/ICU:

   • Severe hypophosphataemia + confusion + arrhythmia risk → requires level 2/3 care
   • May need central venous access for rapid electrolyte replacement

7. Investigations:

   • Repeat electrolytes in 4-6 hours (monitor response to replacement)
   • ABG (assess acid-base status, lactate—tissue hypoxia from 2,3-DPG depletion)
   • CK (rhabdomyolysis risk)
   • ECG (repeat after K/Mg correction)

Ongoing Management:

8. Restart feeding cautiously only when:

   • Phosphate > 0.80 mmol/L, potassium > 3.5 mmol/L, magnesium > 0.70 mmol/L
   • Haemodynamically stable
   • Start at 5 kcal/kg/day (approximately 350 kcal/day for 70 kg) with twice-daily electrolyte monitoring

9. Identify root cause failure: Why was this patient not identified as high-risk pre-feeding? (Alcoholism + 12 days minimal intake = high NICE criteria). Implement safety netting.

This case illustrates the critical importance of pre-feeding risk assessment and prevention."

---

MCQ/SBA Practice

Question 1: A 26-year-old woman with anorexia nervosa (BMI 14.8 kg/m²) is admitted for refeeding. Which of the following is the MOST important intervention to prevent Wernicke's encephalopathy?

A. Oral thiamine 100 mg once daily B. IV Pabrinex (high-dose B vitamins) before commencing nutrition C. Oral multivitamin supplementation D. Intramuscular thiamine 100 mg weekly E. IV thiamine only if confusion develops

Answer: B. IV Pabrinex before commencing nutrition

Explanation: Wernicke's encephalopathy is precipitated by glucose metabolism in thiamine-deficient states. IV high-dose thiamine (Pabrinex) must be given BEFORE nutrition starts to prevent this irreversible complication. Oral thiamine is poorly absorbed in malnourished patients and insufficient. Waiting for confusion is too late—permanent Korsakoff syndrome occurs in 80%.

---

Question 2: In refeeding syndrome, hypophosphataemia causes cardiac dysfunction primarily by:

A. Direct myocardial membrane depolarization B. Depletion of ATP required for myocyte contraction C. Increased sympathetic nervous system activity D. Coronary artery vasospasm E. Direct bradycardic effect on the SA node

Answer: B. Depletion of ATP required for myocyte contraction

Explanation: Phosphate is essential for ATP synthesis. Severe hypophosphataemia depletes cardiac myocyte ATP, impairing contractility (heart failure) and electrical stability (arrhythmias). This is the primary mechanism of cardiac complications in RFS.

---

Question 3: A 68-year-old man develops refeeding syndrome with phosphate 0.35 mmol/L on day 2 of NG feeding. IV phosphate replacement is commenced. Which of the following must be monitored closely during IV phosphate infusion?

A. Serum sodium B. Serum calcium C. Serum chloride D. Blood glucose E. Haemoglobin

Answer: B. Serum calcium

Explanation: Rapid IV phosphate administration can precipitate calcium phosphate, causing acute severe hypocalcaemia (tetany, seizures, arrhythmias). Calcium must be monitored during phosphate infusion, and infusion rate should not exceed 9 mmol/hour.

---

12. Patient and Layperson Explanation

What is Refeeding Syndrome?

Refeeding syndrome is a serious condition that can happen when someone who has not been eating properly for a long time starts eating again. It sounds strange—eating should make you better, right? But the body's chemistry can become dangerously unbalanced when food is reintroduced too quickly.

Why Does It Happen?

When you haven't eaten for a long time (more than a week or two), your body goes into a "survival mode." It switches to burning fat instead of sugar for energy, and the levels of important minerals in your blood—like phosphate, potassium, and magnesium—drop, even though blood tests might look normal at first.

When you start eating again, especially foods with carbohydrates (bread, pasta, sugar), your body releases a hormone called insulin. Insulin tells your body's cells to take in sugar and those minerals from your blood. This causes the levels of phosphate, potassium, and magnesium in your blood to drop suddenly and dangerously low.

What Are the Dangers?

These minerals are crucial for your body to work properly:

• Phosphate helps make energy (called ATP) that your heart, lungs, and muscles need to function
• Potassium keeps your heartbeat regular
• Magnesium helps muscles and nerves work

When they drop too low, you can develop:

• Heart problems: Irregular heartbeat (arrhythmias) or heart failure
• Breathing problems: Weak breathing muscles
• Brain problems: Confusion, seizures, or a condition called Wernicke's encephalopathy (from lack of vitamin B1/thiamine)
• Muscle breakdown (rhabdomyolysis)

In severe cases, refeeding syndrome can be fatal.

Who Is at Risk?

People at highest risk include:

• Individuals with eating disorders like anorexia nervosa
• People who have not eaten for more than 10 days (from illness, surgery, or other reasons)
• Those who are very underweight (BMI less than 16)
• People with chronic alcoholism
• Patients with cancer who have lost a lot of weight
• Elderly or neglected individuals

How Is It Prevented?

The good news is that refeeding syndrome can almost always be prevented if doctors and nurses know you're at risk. Prevention involves:

1. Starting food slowly: If you're high-risk, doctors start with small amounts of calories (10-20% of what you normally need) and increase gradually over a week
2. Giving you vitamin B1 (thiamine) BEFORE you start eating (usually through a drip in your vein)
3. Replacing minerals (phosphate, potassium, magnesium) before and during feeding
4. Checking blood tests daily to catch any problems early
5. Limiting fluids at first to prevent swelling and heart strain

What Should You Expect?

If you're admitted to hospital and doctors are concerned about refeeding syndrome:

• You'll have blood tests every day for the first week or more
• You might have a drip (IV) to give you vitamins and minerals
• Feeding will start slowly—you might feel hungry, but it's important to go slowly for safety
• You might be on a heart monitor (especially if you have an eating disorder or are very unwell)
• You'll be weighed daily to check for fluid retention

Can You Recover?

Yes! With careful management, people recover fully from the risk of refeeding syndrome. The key is patience—allowing your body time to adjust to food again. Once the first 1-2 weeks pass and your body's chemistry stabilizes, you can eat normally.

Important Message

If you or a loved one has not been eating properly for more than a week, please tell your doctor. Early recognition and prevention can save lives.

---

13. References

Primary Guidelines

1. Mehanna HM, Moledina J, Travis J. Refeeding syndrome: what it is, and how to prevent and treat it. BMJ. 2008;336(7659):1495-1498. doi:10.1136/bmj.a301. PMID: 18583681

2. Araujo Castro M, Vázquez Martínez C. The refeeding syndrome. Importance of phosphorus. Med Clin (Barc). 2018;151(4):141-147. doi:10.1016/j.medcli.2017.12.008. PMID: 29448987

3. Fuentebella J, Kerner JA. Refeeding syndrome. Pediatr Clin North Am. 2009;56(5):1201-1210. doi:10.1016/j.pcl.2009.06.006. PMID: 19931071

4. Runde J, Sentongo T. Refeeding Syndrome. Pediatr Ann. 2019;48(11):e446-e450. doi:10.3928/19382359-20191017-02. PMID: 31710364

5. Skowrońska A, Sójta K, Strzelecki D. Refeeding syndrome as treatment complication of anorexia nervosa. Psychiatr Pol. 2019;53(5):1113-1123. doi:10.12740/PP/OnlineFirst/90275. PMID: 31955189

6. Kraft MD, Btaiche IF, Sacks GS. Review of the refeeding syndrome. Nutr Clin Pract. 2005;20(6):625-633. doi:10.1177/0115426505020006625. PMID: 16306300

7. Stanga Z, Brunner A, Leuenberger M, et al. Nutrition in clinical practice—the refeeding syndrome: illustrative cases and guidelines for prevention and treatment. Eur J Clin Nutr. 2008;62(6):687-694. doi:10.1038/sj.ejcn.1602854. PMID: 17609717

8. National Institute for Health and Care Excellence (NICE). Nutrition Support for Adults: Oral Nutrition Support, Enteral Tube Feeding and Parenteral Nutrition (CG32). Published 2006, updated 2017. Available at: https://www.nice.org.uk/guidance/cg32

9. National Collaborating Centre for Acute Care (UK). Nutrition Support for Adults: Oral Nutrition Support, Enteral Tube Feeding and Parenteral Nutrition. London: National Collaborating Centre for Acute Care; 2006. PMID: 21309148

10. Mehanna H, Nankivell PC, Moledina J, Travis J. Refeeding syndrome—awareness, prevention and management. Head Neck Oncol. 2009;1:4. doi:10.1186/1758-3284-1-4. PMID: 19284692

11. Rio A, Whelan K, Goff L, Reidlinger DP, Smeaton N. Occurrence of refeeding syndrome in adults started on artificial nutrition support: prospective cohort study. BMJ Open. 2013;3(1):e002173. doi:10.1136/bmjopen-2012-002173. PMID: 23355664

12. Marinella MA. Refeeding syndrome and hypophosphatemia. J Intensive Care Med. 2005;20(3):155-159. doi:10.1177/0885066605275314. PMID: 15888902

13. Boateng AA, Sriram K, Meguid MM, Crook M. Refeeding syndrome: treatment considerations based on collective analysis of literature case reports. Nutrition. 2010;26(2):156-167. doi:10.1016/j.nut.2009.11.017. PMID: 20122539

14. O'Connor G, Nicholls D, Hudson L, Singhal A. Refeeding low weight hospitalized adolescents with anorexia nervosa: a multicenter randomized controlled trial. Nutr Clin Pract. 2016;31(5):681-689. doi:10.1177/0884533615627267. PMID: 26826259

15. Zeki S, Culkin A, Gabe SM, Nightingale JM. Refeeding hypophosphataemia is more common in enteral than parenteral feeding in adult in patients. Clin Nutr. 2011;30(3):365-368. doi:10.1016/j.clnu.2010.12.001. PMID: 21256638

16. da Silva JSV, Seres DS, Sabino K, et al. ASPEN Consensus Recommendations for Refeeding Syndrome. Nutr Clin Pract. 2020;35(2):178-195. doi:10.1002/ncp.10474. PMID: 32115791

17. Marik PE, Hooper MH. Normocaloric versus hypocaloric feeding on the outcomes of ICU patients: a systematic review and meta-analysis. Intensive Care Med. 2016;42(3):316-323. doi:10.1007/s00134-015-4162-8. PMID: 26699916

18. Hearing SD. Refeeding syndrome. BMJ. 2004;328(7445):908-909. doi:10.1136/bmj.328.7445.908. PMID: 15087326

19. Cahill GF Jr. Fuel metabolism in starvation. Annu Rev Nutr. 2006;26:1-22. doi:10.1146/annurev.nutr.26.061505.111258. PMID: 16848698

20. Crook MA, Hally V, Panteli JV. The importance of the refeeding syndrome. Nutrition. 2001;17(7-8):632-637. doi:10.1016/s0899-9007(01)00542-1. PMID: 11448586

Guidelines and Society Statements

21. Royal College of Psychiatrists. MARSIPAN: Management of Really Sick Patients with Anorexia Nervosa (CR189). 2nd edition. London: Royal College of Psychiatrists; 2014. Updated 2022. Available at: https://www.rcpsych.ac.uk/improving-care/campaigning-for-better-mental-health-policy/college-reports/2014-college-reports/marsipan-cr189-jan-2014

22. Friedli N, Stanga Z, Sobotka L, et al. Revisiting the refeeding syndrome: Results of a systematic review. Nutrition. 2017;35:151-160. doi:10.1016/j.nut.2016.05.016. PMID: 27908549

Additional Evidence

23. Aubier M, Murciano D, Lecocguic Y, et al. Effect of hypophosphatemia on diaphragmatic contractility in patients with acute respiratory failure. N Engl J Med. 1985;313(7):420-424. doi:10.1056/NEJM198508153130705. PMID: 4010751

24. Valla FV, Baudin F, Gaillard-Le-Roux B, et al. Hypophosphatemia in critically ill children: incidence, associated risk factors and correlation with illness severity. J Crit Care. 2015;30(2):441.e7-441.e12. doi:10.1016/j.jcrc.2014.11.001. PMID: 25465285

25. Amanzadeh J, Reilly RF Jr. Hypophosphatemia: an evidence-based approach to its clinical consequences and management. Nat Clin Pract Nephrol. 2006;2(3):136-148. doi:10.1038/ncpneph0124. PMID: 16932412

26. Knochel JP. The pathophysiology and clinical characteristics of severe hypophosphatemia. Arch Intern Med. 1977;137(2):203-220. PMID: 836118

27. Mount DB, Zandi-Nejad K. Disorders of potassium balance. In: Brenner BM, ed. Brenner and Rector's The Kidney. 8th ed. Philadelphia: Saunders Elsevier; 2008:547-587.

28. Jahnen-Dechent W, Ketteler M. Magnesium basics. Clin Kidney J. 2012;5(Suppl 1):i3-i14. doi:10.1093/ndtplus/sfr163. PMID: 26069818

29. Day E, Bentham PW, Callaghan R, Kuruvilla T, George S. Thiamine for prevention and treatment of Wernicke-Korsakoff Syndrome in people who abuse alcohol. Cochrane Database Syst Rev. 2013;2013(7):CD004033. doi:10.1002/14651858.CD004033.pub3. PMID: 23881659

30. Sechi G, Serra A. Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurol. 2007;6(5):442-455. doi:10.1016/S1474-4422(07)70104-7. PMID: 17434099

31. Thomson AD, Marshall EJ, Bell D. Time to act on the inadequate management of Wernicke's encephalopathy in the UK. Alcohol Alcohol. 2013;48(1):4-8. doi:10.1093/alcalc/ags111. PMID: 23019235

32. Bankir L, Bichet DG, Morgenthaler NG. Vasopressin: physiology, assessment and osmosensation. J Intern Med. 2017;282(4):284-297. doi:10.1111/joim.12645. PMID: 28695687

33. Gaasbeek A, Meinders AE. Hypophosphatemia: an update on its etiology and treatment. Am J Med. 2005;118(10):1094-1101. doi:10.1016/j.amjmed.2005.02.014. PMID: 16194637

34. Skipper A. Refeeding syndrome or refeeding hypophosphatemia: a systematic review of cases. Nutr Clin Pract. 2012;27(1):34-40. doi:10.1177/0884533611427916. PMID: 22307490

35. Khan LU, Ahmed J, Khan S, Macfie J. Refeeding syndrome: a literature review. Gastroenterol Res Pract. 2011;2011:410971. doi:10.1155/2011/410971. PMID: 21747826

36. Cohn JN, Kowey PR, Whelton PK, Prisant LM. New guidelines for potassium replacement in clinical practice: a contemporary review by the National Council on Potassium in Clinical Practice. Arch Intern Med. 2000;160(16):2429-2436. doi:10.1001/archinte.160.16.2429. PMID: 10979053

37. McClave SA, Taylor BE, Martindale RG, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr. 2016;40(2):159-211. doi:10.1177/0148607115621863. PMID: 26773077

38. Royal College of Psychiatrists. Junior MARSIPAN: Management of Really Sick Patients Under 18 with Anorexia Nervosa (CR168). London: Royal College of Psychiatrists; 2012. Available at: https://www.rcpsych.ac.uk

39. Sriram K, Meguid MM, Lim SC. Refeeding syndrome: an important complication following obesity surgery. Nutr Rev. 2008;66(9):522-525. doi:10.1111/j.1753-4887.2008.00093.x. PMID: 18752476

40. Brown CA, Seidler NW, Tintinalli JE. Hypophosphatemia. In: Tintinalli JE, Stapczynski JS, Ma OJ, et al., eds. Tintinalli's Emergency Medicine: A Comprehensive Study Guide. 8th ed. New York: McGraw-Hill; 2016:Chapter 23.

41. Cano N, Fiaccadori E, Tesinsky P, et al. ESPEN guidelines on enteral nutrition: adult renal failure. Clin Nutr. 2006;25(2):295-310. doi:10.1016/j.clnu.2006.01.023. PMID: 16697495

42. Saunders J, Smith T. Malnutrition: causes and consequences. Clin Med (Lond). 2010;10(6):624-627. doi:10.7861/clinmedicine.10-6-624. PMID: 21413492

43. Marinella MA. The refeeding syndrome and hypophosphatemia. Nutr Rev. 2003;61(9):320-323. doi:10.1301/nr.2003.sept.320-323. PMID: 14552067

44. Schnitker MA, Mattman PE, Bliss TL. A clinical study of malnutrition in Japanese prisoners of war. Ann Intern Med. 1951;35(1):69-96. doi:10.7326/0003-4819-35-1-69. PMID: 14857388

45. Keys A, Brozek J, Henschel A, Mickelsen O, Taylor HL. The Biology of Human Starvation (2 volumes). Minneapolis: University of Minnesota Press; 1950.

46. Liamis G, Milionis HJ, Elisaf M. Medication-induced hypophosphatemia: a review. QJM. 2010;103(7):449-459. doi:10.1093/qjmed/hcq039. PMID: 20406990

47. Vignaud M, Constantin JM, Ruivard M, et al. Refeeding syndrome influences outcome of anorexia nervosa patients in intensive care unit: an observational study. Crit Care. 2010;14(5):R172. doi:10.1186/cc9274. PMID: 20920212

48. Kohn MR, Golden NH, Shenker IR. Cardiac arrest and delirium: presentations of the refeeding syndrome in severely malnourished adolescents with anorexia nervosa. J Adolesc Health. 1998;22(3):239-243. doi:10.1016/s1054-139x(97)00163-8. PMID: 9502012

49. Genton L, Cani PD, Schrenzel J. Alterations of gut barrier and gut microbiota in food restriction, food deprivation and protein-energy wasting. Clin Nutr. 2015;34(3):341-349. doi:10.1016/j.clnu.2014.10.003. PMID: 25453395

50. Garber AK, Michihata N, Hetnal K, Shaffer ML, Moscicki AB. A prospective examination of weight gain in hospitalized adolescents with anorexia nervosa on a recommended refeeding protocol. J Adolesc Health. 2012;50(1):24-29. doi:10.1016/j.jadohealth.2011.06.011. PMID: 22188830

51. Golden NH, Keane-Miller C, Sainani KL, Kapphahn CJ. Higher caloric intake in hospitalized adolescents with anorexia nervosa is associated with reduced length of stay and no increased rate of refeeding syndrome. J Adolesc Health. 2013;53(5):573-578. doi:10.1016/j.jadohealth.2013.05.014. PMID: 23871897

52. Garber AK, Sawyer SM, Golden NH, et al. A systematic review of approaches to refeeding in patients with anorexia nervosa. Int J Eat Disord. 2016;49(3):293-310. doi:10.1002/eat.22482. PMID: 26661289

53. Hale MD, Kamel A, O'Reilly M, Beattie RM, Johnson T. Preventing Wernicke's encephalopathy in anorexia nervosa: A systematic review. Eur Eat Disord Rev. 2019;27(2):114-133. doi:10.1002/erv.2649. PMID: 29984541

54. Crook MA. Refeeding syndrome: problems with definition and management. Nutrition. 2014;30(11-12):1448-1455. doi:10.1016/j.nut.2014.03.026. PMID: 25280403

55. Olthof LE, Koekkoek WAC, van Setten C, Kars JCN, van Blokland D, van Zanten ARH. Impact of caloric intake in critically ill patients with, and without, refeeding syndrome: A retrospective study. Clin Nutr. 2018;37(5):1609-1617. doi:10.1016/j.clnu.2017.08.001. PMID: 28843494

56. Solomon SM, Kirby DF. The refeeding syndrome: a review. JPEN J Parenter Enteral Nutr. 1990;14(1):90-97. doi:10.1177/014860719001400190. PMID: 2109122

---

Last Updated: 2026-01-06 Evidence Level: High Target Examinations: MRCP, FRACP, MRCPCH, Intensive Care (FFICM, FCICM), Clinical Nutrition